Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/09/2011 | EP1966240B1 Lactoferrin peptides useful as cell-penetrating peptides |
03/09/2011 | EP1945775B1 Method for the production of gamma-linolenic acid and/or stearidonic acid in transgenic brassicaceae and linaceae |
03/09/2011 | EP1888119B1 Pegylated g-csf polypeptides and methods of producing same |
03/09/2011 | EP1842857B1 Mutant interferon proteins and use thereof |
03/09/2011 | EP1828242B1 Process for preparing high levels of interferon beta |
03/09/2011 | EP1749020B1 Method for the purification of polymers carrying a lipophilic group |
03/09/2011 | EP1748069B1 Follistatin mutant polypeptide |
03/09/2011 | EP1709177B1 Dna-sequence and recombinant production of group 4 major allergens from cereals |
03/09/2011 | EP1688498B1 A recombinant protein with cancer suppression action, its encoding gene and use |
03/09/2011 | EP1539996B1 Method of producing plants having enhanced transpiration efficiency and plants produced therefrom |
03/09/2011 | EP1458852B1 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
03/09/2011 | EP1364963B1 A novel natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof |
03/09/2011 | EP1355918B1 Recombinant protective protein from $i(streptococcus pneumoniae) |
03/09/2011 | EP1315513B1 "pseudo"-native chemical ligation |
03/09/2011 | EP1276887B1 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
03/09/2011 | EP1181320B1 Somatic transgene immunization and related methods |
03/09/2011 | EP0994949B1 Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
03/09/2011 | CN101984059A Gossypium barbadense DREB transcription factor gene and application thereof |
03/09/2011 | CN101984045A The Cry8Na1 gene of bacillus thuringiensis, expression protein and application thereof |
03/09/2011 | CN101983969A Method of preparing ginkgo protein superfine powders |
03/08/2011 | USRE42211 Relating to binding proteins for recognition of DNA |
03/08/2011 | US7902441 Group of recessive oncogenes, Fus1, 101F6, Gene 21 (NPRL2), Gene 26 (CACNA2D2), Luca 1 (HYAL1), Luca 2 (HYAL2), PL6 ,123F2 (RaSSFI), SEM A3 and Beta* (BLU), defined by homozygous deletion in lung cancer, have been located, isolated at 3p21.3 |
03/08/2011 | US7902424 Transcription factor stress-related proteins and methods of use in plants |
03/08/2011 | US7902421 Animal model for schizophrenia |
03/08/2011 | US7902349 Nucleic acids encoding protective epitopes of adenyl cyclase-haemolysin (AC-Hly) |
03/08/2011 | US7902346 Fusion protein comprising FK506 binding protein and DNA encoding the same |
03/08/2011 | US7902337 Isolated soybean cyst nematode and soybean sudden death syndrome polypeptides |
03/08/2011 | US7902335 Heat-stable recA mutant protein and a nucleic acid amplification method using the heat-stable recA mutant protein |
03/08/2011 | US7902334 Pesticidally active proteins and polynucleotides obtainable from Paenibacillus species |
03/08/2011 | US7902333 activated ester of the carboxyl-containing compound (carboxylic acid) is reacted with H217O or H218O in the presence of an activator; labelled amino acid |
03/08/2011 | US7902331 Forisomes, method for their isolation, and their use as a molecular working machine |
03/08/2011 | US7902328 Amyloid β(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
03/08/2011 | US7902165 Inhibiting of the proliferation of tumor cells is mediated by upregulation of the activity of p53 |
03/08/2011 | US7902153 Alpha-conotoxin peptides |
03/08/2011 | US7902151 Methods and compositions for modulating immunity |
03/08/2011 | US7902149 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
03/08/2011 | US7902146 Therapeutic, prophylactic, and diagnostic agent for cancer, useful for characterizing cancer cells with individual properties |
03/08/2011 | US7902144 Therapeutic and diagnostic ligand systems comprising transport molecule binding properties and medicaments containing the same |
03/08/2011 | US7901943 Materials and methods for controlling isotope effects during fractionation of analytes |
03/08/2011 | US7901935 Nucleic acid compositions conferring disease resistance |
03/08/2011 | US7901919 Chimaeric phages |
03/08/2011 | US7901917 Human aminoacyl-tRNA synthetase polypeptides useful for the regulation of angiogenesis |
03/08/2011 | US7901911 Polynucleotide encoding IL-6 receptor/IL-6 fusion protein |
03/08/2011 | US7901907 Process for production of Helicobacter pylori bacterioferritin |
03/08/2011 | US7901900 quantitatively or qualitatively determine human low molecular weight CD14 with high sensitivity and specificity in a simple manner |
03/08/2011 | US7901898 Tuberculosis diagnostic test |
03/08/2011 | US7901893 NPC1L1 (NPC3) and methods of identifying ligands thereof |
03/08/2011 | US7901718 Process for the extraction, purification and enzymatic modification of soy 7S globulin α′ subunit for use as hypocholesterolemizing agent |
03/08/2011 | US7901693 Compositions and methods for WT1 specific immunotherapy |
03/08/2011 | US7901692 Nontypeable Haemophilus influenzae virulence factors |
03/08/2011 | US7901690 Comprised of different nucleic acid sequences from distinct genetic clades; reduced mutation efficacy loss |
03/08/2011 | US7901689 Chimeric peptides as immunogens, antibodies thereto, and methods for immunization using chimeric peptides or antibodies |
03/08/2011 | US7901686 drug screening; reaction mixture includes a hedgehog polypeptide, a patched polypeptide, and a test compound; receptor binding assay |
03/08/2011 | US7901682 Compositions and methods for the treatment and prevention of cancer, angiogenesis, and inflammation |
03/08/2011 | US7901681 Trypanosome derived apoptotic factors (TAF) |
03/08/2011 | US7901670 purification from a recombinant human interferon beta-containing culture by performing affinity chromatography and reversed-phase high-performance liquid chromatography |
03/08/2011 | US7901507 Crystal structure of an angiotensin-converting enzyme (ACE) and uses thereof |
03/08/2011 | CA2468415C Non-human animal model of systemic lupus erythematosus |
03/08/2011 | CA2465667C New peptides - analogs of human growth hormone-releasing hormone |
03/08/2011 | CA2343840C Use of a cytokine-producing lactococcus strain to treat colitis |
03/08/2011 | CA2329054C A novel polypeptide hormone phosphatonin |
03/08/2011 | CA2309883C Diacylglycerol o-acyltransferase |
03/08/2011 | CA2285676C Methods and materials for making and using transgenic dicamba-degrading organisms |
03/08/2011 | CA2240516C Novel tyrosine kinase receptors and ligands |
03/08/2011 | CA2137377C Retinal pigmented epithelium derived neurotrophic factor |
03/03/2011 | WO2011026132A2 Methods and compositions for the inhibition of transplant rejection |
03/03/2011 | WO2011026122A2 B7-h4 fusion proteins and methods of use thereof |
03/03/2011 | WO2011026111A1 Oral delivery of a vaccine to the large intestine to induce mucosal immunity |
03/03/2011 | WO2011026081A1 Chitin-binding proteins as biomarkers |
03/03/2011 | WO2011026015A2 Stabilized melanocortin ligands |
03/03/2011 | WO2011025905A1 Urocortin 2 analogs and uses thereof |
03/03/2011 | WO2011025394A1 Complete genome sequence of the methanogen methanobrevibacter ruminantium |
03/03/2011 | WO2011025158A2 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof |
03/03/2011 | WO2011025077A1 Novel brazzein variant having higher sweetness and method for preparing multi-variant |
03/03/2011 | WO2011025050A1 Apoptosis inducer |
03/03/2011 | WO2011025011A1 Protein having glycoalkaloid biosynthase activity, and gene encoding same |
03/03/2011 | WO2011024791A1 Method for producing t cell population under presence of retinoic acid |
03/03/2011 | WO2011024748A1 Modified peptide vaccine derived from influenza m2 |
03/03/2011 | WO2011024428A1 Breast cancer related gene c12orf32 |
03/03/2011 | WO2011024096A1 Additive for bioleaching that is substantially made up of the licanantase lipoprotein, and bioleaching process to which this additive is added to increase the recovery of copper |
03/03/2011 | WO2011024025A1 An erythropoietin analogue and a method thereof |
03/03/2011 | WO2011024024A1 A process for recovering darbepoeitin alfa isoforms |
03/03/2011 | WO2011023999A1 Early growth transcription factors and their therapeutic use |
03/03/2011 | WO2011023914A1 Proteins used for the diagnosis of lyme borreliosis |
03/03/2011 | WO2011023909A1 Proteins used for the diagnosis of lyme borreliosis |
03/03/2011 | WO2011023816A2 Peptides of cenp-a and use thereof |
03/03/2011 | WO2011023801A1 Hcv ns3/4a replicon shuttle vectors |
03/03/2011 | WO2011023785A1 Targeting tissue factor to activated platelets |
03/03/2011 | WO2011023740A1 Genetic vasectomy by overexpression of prml-egfp fusion protein in spermatids |
03/03/2011 | WO2011023685A1 Il-17 binding compounds and medical uses thereof |
03/03/2011 | WO2011023522A1 Antibody fusion-mediated plant resistance against oomycota |
03/03/2011 | WO2011023250A1 Treatment of neurological or neurodegenerative disorders |
03/03/2011 | WO2011023249A1 Treatment of neurological of neurodegenerative disorder |
03/03/2011 | WO2011023213A1 Modified chemodenervating agents |
03/03/2011 | WO2011022930A1 Proteins relating to grain shape and leaf shape of rice, coding genes and uses thereof |
03/03/2011 | WO2011022809A1 Fusarium and fusarium mycotoxin biocontrol |
03/03/2011 | WO2011022794A1 Process to extract the collagen protein from bovine hide |
03/03/2011 | WO2011022780A1 Methods for the diagnosis and prognosis of autoimmune disease |
03/03/2011 | WO2010150230A8 Bacterial expression of an artificial gene for the production of crm197 and its derivatives |
03/03/2011 | WO2010148496A8 Lipidated tumor- associated antigens and immunotherapeutic compositions |